DJ Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ advanced 4.13% to $2.27 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.65% to 44,713.58 and the NASDAQ Composite Index falling 3.07% to 19,341.83.
Inovio Pharmaceuticals Inc. closed 84.61% short of its 52-week high of $14.75, which the company reached on April 1st.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 4.13% to $152.89, Statera Biopharma Inc. (STAB) fell 99.00% to $0.00, and Pfizer Inc. $(PFE)$ rose 2.95% to $26.86.
Trading volume (1.1 M) remained 6,176 below its 50-day average volume of 1.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled January 27, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
January 27, 2025 17:27 ET (22:27 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。